SKAN Group AGXSWX:SKAN +2.16%82 ROA % is 11.67% as of Dec. 2025, which is 158% above its 10-year median of 4.52. GuruFocus rates XSWX:SKAN with a GF Score™ of 82/100 and a GF Value™ of CHF85.80 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 854 Medical Devices & Instruments companies, SKAN Group AG ranks better than 65.46% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. SKAN Group AG's annualizedNet Income for the quarter that ended in Dec. 2025 was CHF50.3 Mil.
SKAN Group AG's average Total Assets over the quarter that ended in Dec. 2025 was CHF431.3 Mil. Therefore, SKAN Group AG's annualized ROA % for the quarter that ended in Dec. 2025 was 11.67%.
The historical rank and industry rank for SKAN Group AG's ROA % or its related term are showing as below:
XSWX:SKAN'
s ROA % Range Over the Past 10 Years
Min: 1.75 Med: 4.52 Max: 10.24
Current: 3.91
During the past 6 years, SKAN Group AG's highest ROA % was 10.24%. The lowest was 1.75%. And the median was 4.52%.
XSWX:SKAN's ROA % is ranked better than 65.46% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.555
vs XSWX:SKAN: 3.91
SKAN Group AG (XSWX:SKAN) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
SKAN Group AG ROA % Related Terms
SKAN Group AG ROA % Historical Data
* Premium members only.
The historical data trend for SKAN Group AG's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, SKAN Group AG's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SKAN Group AG ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's ROA % distribution charts can be found below:
* The bar in red indicates where SKAN Group AG's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
SKAN Group AG (XSWX:SKAN) has a ROA % of 11.67% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on SKAN Group AG and its competitors. This is 158% above median its historical median of 4.52. Over the past decade, SKAN Group AG's ROA % has ranged from 1.75 to 10.24. According to the industry distribution chart, SKAN Group AG ranks #295 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 34.5%.
Is SKAN Group AG's ROA % too high?
SKAN Group AG's current ROA % of 11.67% is 158% above median its 10-year median of 4.52. Over the past 10 years, this metric has ranged from a low of 1.75 to a high of 10.24. The Medical Devices & Instruments industry median ROA % is 0.56. SKAN Group AG's value of 11.67% is 2002.7% above this industry median. Based on the distribution chart, SKAN Group AG ranks #295 out of 854 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, SKAN Group AG has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SKAN Group AG ranks #295 out of 854 companies for ROA %. This puts SKAN Group AG in the upper half of its industry. The industry median ROA % is 0.56. SKAN Group AG's value of 11.67% is 2002.7% above this benchmark. Historically, SKAN Group AG's own ROA % has ranged from 1.75 to 10.24 over the past decade. While the company's 10-year median is 4.52 vs. the industry median of 0.56, SKAN Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.56, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SKAN Group AG's current ROA % of 11.67% is 2002.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on SKAN Group AG and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SKAN Group AG's current ROA % is 11.67%, which is 158% above median its own 10-year median of 4.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (XSWX:SKAN) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF85.80, compared to a current price of CHF56.80 — trading 33.8% below its estimated fair value. The current ROA % is 11.67%, which is 158% above median its 10-year median of 4.52 and 2002.7% above the Medical Devices & Instruments industry median of 0.56. SKAN Group AG's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For SKAN Group AG (XSWX:SKAN), the current ROA % is 11.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SKAN Group AG (XSWX:SKAN) Overvalued in 2026?
Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued.
The current stock price of CHF56.80 is trading 33.8% below its estimated GF Value™ of CHF85.80.
GuruFocus considers SKAN Group AG to be Significantly Undervalued.
Key valuation signals for XSWX:SKAN:
ROA %: 11.67% (158% above median its 10-year median of 4.52)
GF Value™: CHF85.80 vs. price of CHF56.80 (33.8% below fair value)
Industry Position: 2002.7% above the Medical Devices & Instruments median (#295 of 854)
No single metric tells the full story. See the XSWX:SKAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
82GF Score
Get the complete analysis for XSWX:SKAN
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SKAN has been successfully added to your 
